Alto Ingredients, Inc.ALTO
| Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
---|
Consolidated net income (loss) | -4 | -43 | -1 | 26 | 2 | -38 | -68 | -101 | -17 | 46 | -42 |
---|
Depreciation and amortization of intangibles | - | - | - | - | - | - | - | - | - | 23 | 25 |
---|
Asset impairments | - | - | - | - | - | - | - | 29 | 24 | 3 | - |
---|
Income from loan forgiveness | - | - | -3 | -2 | - | - | - | -7 | - | - | - |
---|
Fair value adjustments | - | - | 1 | 35 | 1 | -0 | - | - | - | - | - |
---|
(Gain) loss on (sale) disposal of assets | - | - | - | - | - | - | - | - | - | - | -2 |
---|
Inventory valuation | 0 | 1 | 0 | 1 | - | 3 | -0 | - | -0 | - | 5 |
---|
Gains on derivative instruments | -0 | - | - | - | - | - | - | 1 | 15 | 22 | 19 |
---|
Amortization of deferred financing costs | - | - | - | - | - | - | - | - | - | - | 0 |
---|
Amortization of debt discounts (premiums) | - | - | 1 | 2 | 2 | 1 | 1 | 1 | -0 | -0 | 0 |
---|
Stock-based compensation | - | - | - | 2 | 3 | 4 | 3 | 3 | 3 | - | 3 |
---|
Bad debt expense (recovery) | -0 | - | 0 | -0 | - | - | 0 | 0 | 0 | 0 | -0 |
---|
Accounts receivable | 2 | 2 | 9 | -1 | 25 | -18 | -13 | 7 | -31 | 44 | -24 |
---|
Inventories | -1 | -1 | 2 | -4 | -1 | -5 | -4 | 3 | -19 | - | 15 |
---|
Other current assets | - | 4 | 7 | -1 | 4 | -7 | -0 | - | -1 | - | -8 |
---|
Operating leases | - | - | - | - | - | - | - | - | - | - | -5 |
---|
Assets held-for-sale | - | - | - | - | - | - | - | - | -1 | 3 | - |
---|
Accounts payable and accrued expenses | -2 | 0 | 9 | 2 | 9 | -6 | 4 | -3 | -20 | 13 | 21 |
---|
Net cash provided by operating activities | -4 | -21 | - | - | - | 37 | 2 | -23 | 72 | 27 | 6 |
---|
Proceeds from principal payments on notes receivable | - | - | - | - | - | - | - | - | - | - | 15 |
---|
Purchase of Eagle Alcohol, net of cash acquired | 9 | - | - | - | - | 30 | - | - | - | - | 15 |
---|
Proceeds from sale of Stockton | - | - | - | - | - | - | - | - | - | 24 | - |
---|
Proceeds from sale of interests in PAL | - | - | - | - | - | - | - | - | 20 | - | - |
---|
Proceeds from Magic Valley asset sale | - | - | - | - | - | - | - | - | 10 | - | - |
---|
Additions to property and equipment | 2 | 2 | 4 | 13 | 19 | 21 | 15 | 3 | 7 | 16 | 38 |
---|
Net cash provided by (used in) investing activities | -11 | -12 | - | - | - | -50 | -15 | -3 | 23 | 27 | -38 |
---|
Net proceeds from term loan | - | - | - | - | - | - | - | - | - | - | 59 |
---|
Net proceeds from (payments on) Kinergy’s line of credit | - | - | -1 | - | -11 | -0 | 8 | 21 | -46 | 18 | -32 |
---|
Debt issuance costs | - | - | - | - | 2 | 1 | - | 1 | - | - | 5 |
---|
Preferred stock dividend payments | - | 1 | 1 | 3 | 1 | 1 | 1 | 1 | - | 3 | 1 |
---|
Stock repurchases | - | - | - | - | - | - | - | - | - | - | 1 |
---|
Proceeds from warrant exercises | - | - | 2 | 44 | 1 | 1 | - | - | 6 | - | - |
---|
Proceeds from CARES Act loans | - | - | - | - | 97 | - | - | - | - | - | - |
---|
Payments on plant borrowings | - | - | - | - | - | - | - | - | - | 30 | - |
---|
Payments on senior notes | - | - | 6 | 14 | - | - | 2 | 4 | 40 | 26 | - |
---|
Net cash provided by (used in) financing activities | 16 | 32 | - | - | - | -1 | -9 | 19 | -66 | -40 | 19 |
---|
Net increase (decrease) in cash, cash equivalents and restricted cash | - | - | - | - | - | - | - | - | 29 | 14 | -13 |
---|
Cash and cash equivalents | - | - | - | - | - | - | - | - | - | 51 | 36 |
---|
Restricted cash | - | - | - | - | - | - | - | - | - | 12 | 13 |
---|
Total cash, cash equivalents and restricted cash | - | - | - | - | - | - | - | - | - | 62 | 50 |
---|
Interest paid (net of capitalized interest) | - | 9 | 8 | 7 | 11 | 11 | 15 | 19 | 17 | 3 | 2 |
---|
Capitalized interest | - | - | - | - | - | - | - | - | - | - | 1 |
---|
Income tax payments (refunds) | - | - | - | 18 | 5 | 6 | 1 | - | 1 | -0 | 2 |
---|